glp-1 impact on bariatric surgery Drugs vs. Dip in bariatric surgeries shows

[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Cummings J.L., Atri A., Feldman H.H., Hansson O., Sano M., Knop F.K., et al

Furthermore, in most studies concerning the chronic effects of GLP-1 on BP, BP is not the primary or pre-established endpoint and most data comes from studies in T2DM

"Is this permanent?" No

This proportion can vary considerably depending on several factors: Rate of weight loss : Rapid weight loss tends to result in greater proportional lean mass loss Baseline body composition : Individuals with lower initial fat mass may lose proportionally more lean tissue Protein intake : Inadequate dietary protein increases muscle protein breakdown Physical activity levels : Resistance training and adequate physical activity help preserve muscle mass Age : Older adults are more susceptible to muscle loss during weight reduction The concern with GLP-1 medications centres on whether they cause disproportionate muscle loss compared to other weight loss methods

Metabolic Signaling Pathway Studies: Examining downstream biomarker modulation and pathway integration related to nutrient-sensing and energy-regulation signaling systems

Thus, the conclusion seems to be justified that chronic exposure to clinically effective doses of GLP-1 receptor agonists does not lead to elevated calcitonin concentrations